Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China
Condition(s):Macular Edema; Retinal Vein OcclusionLast Updated:March 31, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Macular Edema; Retinal Vein OcclusionLast Updated:March 31, 2023Completed
Condition(s):Glaucoma; CataractLast Updated:January 31, 2024Terminated
Condition(s):PterygiumLast Updated:April 6, 2022Completed
Condition(s):Diabetic Macular EdemaLast Updated:December 2, 2015Completed
Condition(s):CataractLast Updated:December 11, 2020Completed
Condition(s):Wet Macular DegenerationLast Updated:April 6, 2018Completed
Condition(s):Epiretinal Membrane; Cellophane Maculopathy; Macular Edema; Retinal EdemaLast Updated:May 13, 2015Completed
Condition(s):Proliferative Diabetic RetinopathyLast Updated:January 30, 2024Completed
Condition(s):Graft Vs Host DiseaseLast Updated:January 5, 2022Withdrawn
Condition(s):Non-hodgkins Lymphoma; Hodgkins Lymphoma; Multiple MyelomaLast Updated:July 24, 2017Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.